Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Clinical trial NCT03477396 · COMPLETED

Trial details

NCT number: NCT03477396
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor and/or Progesterone Receptor Positive HER2/Neu Negative Stage IV Breast Cancer AJCC v6 and v7

Start date: 2018-06-14
Primary completion: 2021-09-29
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.